 | • レポートコード：MRC2-11QY03235 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は生物製剤のグローバル市場について調査・分析したレポートです。種類別（治療用タンパク質、モノクローナル抗体、ワクチン）市場規模、用途別（病院、外来外科センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別生物製剤の競争状況、市場シェア ・世界の生物製剤市場：種類別市場規模 2015年-2020年（治療用タンパク質、モノクローナル抗体、ワクチン） ・世界の生物製剤市場：種類別市場規模予測 2021年-2026年（治療用タンパク質、モノクローナル抗体、ワクチン） ・世界の生物製剤市場：用途別市場規模 2015年-2020年（病院、外来外科センター、その他） ・世界の生物製剤市場：用途別市場規模予測 2021年-2026年（病院、外来外科センター、その他） ・北米の生物製剤市場分析：米国、カナダ ・ヨーロッパの生物製剤市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの生物製剤市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の生物製剤市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの生物製剤市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bristol-Myers Squibb、Eli Lilly、Takeda、Pfizer、Amgen、F. Hoffmann-La Roche、Johnson & Johnson、Merck、Abbott Laboratories、Baxter、Novartis、Biogen、GlaxoSmithKline ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
The international biological drugs market is envisaged to grow at a handsome rate in the next few years. However, it could face challenges in the form of various product parameters, strict regulatory pathways and manufacturing processes, and longer product approvals, although biological drugs have historically shown better approval rates than conventional ones. Additionally, small players could find it difficult to enter the market because of the requirement of high capital expenditure.
The world biological drugs market is predicted to gain momentum with rising prevalence of chronic diseases such as cancer and diabetes across the globe. Demand for biological drugs could swell with the expansion of geriatric population at the global level. Currently growing inclination toward adoption of personalized medicines and strong research and development efforts taken to introduce new and powerful biological drugs are foretold to set the tone for a significant rise in demand.
Market Analysis and Insights: Global Biological Drugs Market
The global Biological Drugs market size is projected to reach US$ 292500 million by 2026, from US$ 268200 million in 2020, at a CAGR of 8.2%% during 2021-2026.
Global Biological Drugs Scope and Market Size
Biological Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biological Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Biological Drugs market is segmented into
Therapeutic Protein
Monoclonal Antibody
Vaccine
Segment by Application, the Biological Drugs market is segmented into
Hospitals
Ambulatory Surgical Centers
Others
Regional and Country-level Analysis
The Biological Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Biological Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Biological Drugs Market Share Analysis
Biological Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Biological Drugs business, the date to enter into the Biological Drugs market, Biological Drugs product introduction, recent developments, etc.
The major vendors covered:
Bristol-Myers Squibb
Eli Lilly
Takeda
Pfizer
Amgen
F. Hoffmann-La Roche
Johnson & Johnson
Merck
Abbott Laboratories
Baxter
Novartis
Biogen
GlaxoSmithKline
1 Study Coverage
1.1 Biological Drugs Product Introduction
1.2 Market Segments
1.3 Key Biological Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Biological Drugs Market Size Growth Rate by Type
1.4.2 Therapeutic Protein
1.4.3 Monoclonal Antibody
1.4.4 Vaccine
1.5 Market by Application
1.5.1 Global Biological Drugs Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Biological Drugs Market Size, Estimates and Forecasts
2.1.1 Global Biological Drugs Revenue 2015-2026
2.1.2 Global Biological Drugs Sales 2015-2026
2.2 Global Biological Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Biological Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Biological Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Biological Drugs Competitor Landscape by Players
3.1 Biological Drugs Sales by Manufacturers
3.1.1 Biological Drugs Sales by Manufacturers (2015-2020)
3.1.2 Biological Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Biological Drugs Revenue by Manufacturers
3.2.1 Biological Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Biological Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Biological Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Biological Drugs Revenue in 2019
3.2.5 Global Biological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Biological Drugs Price by Manufacturers
3.4 Biological Drugs Manufacturing Base Distribution, Product Types
3.4.1 Biological Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biological Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Biological Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Biological Drugs Market Size by Type (2015-2020)
4.1.1 Global Biological Drugs Sales by Type (2015-2020)
4.1.2 Global Biological Drugs Revenue by Type (2015-2020)
4.1.3 Biological Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Biological Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Biological Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Biological Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Biological Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Biological Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Biological Drugs Market Size by Application (2015-2020)
5.1.1 Global Biological Drugs Sales by Application (2015-2020)
5.1.2 Global Biological Drugs Revenue by Application (2015-2020)
5.1.3 Biological Drugs Price by Application (2015-2020)
5.2 Biological Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Biological Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Biological Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Biological Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Biological Drugs by Country
6.1.1 North America Biological Drugs Sales by Country
6.1.2 North America Biological Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Biological Drugs Market Facts & Figures by Type
6.3 North America Biological Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Biological Drugs by Country
7.1.1 Europe Biological Drugs Sales by Country
7.1.2 Europe Biological Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Biological Drugs Market Facts & Figures by Type
7.3 Europe Biological Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Biological Drugs by Region
8.1.1 Asia Pacific Biological Drugs Sales by Region
8.1.2 Asia Pacific Biological Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Biological Drugs Market Facts & Figures by Type
8.3 Asia Pacific Biological Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Biological Drugs by Country
9.1.1 Latin America Biological Drugs Sales by Country
9.1.2 Latin America Biological Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Biological Drugs Market Facts & Figures by Type
9.3 Central & South America Biological Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Biological Drugs by Country
10.1.1 Middle East and Africa Biological Drugs Sales by Country
10.1.2 Middle East and Africa Biological Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Biological Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Biological Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Corporation Information
11.1.2 Bristol-Myers Squibb Description and Business Overview
11.1.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bristol-Myers Squibb Biological Drugs Products Offered
11.1.5 Bristol-Myers Squibb Related Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Corporation Information
11.2.2 Eli Lilly Description and Business Overview
11.2.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Eli Lilly Biological Drugs Products Offered
11.2.5 Eli Lilly Related Developments
11.3 Takeda
11.3.1 Takeda Corporation Information
11.3.2 Takeda Description and Business Overview
11.3.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Takeda Biological Drugs Products Offered
11.3.5 Takeda Related Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Description and Business Overview
11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Pfizer Biological Drugs Products Offered
11.4.5 Pfizer Related Developments
11.5 Amgen
11.5.1 Amgen Corporation Information
11.5.2 Amgen Description and Business Overview
11.5.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Amgen Biological Drugs Products Offered
11.5.5 Amgen Related Developments
11.6 F. Hoffmann-La Roche
11.6.1 F. Hoffmann-La Roche Corporation Information
11.6.2 F. Hoffmann-La Roche Description and Business Overview
11.6.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.6.4 F. Hoffmann-La Roche Biological Drugs Products Offered
11.6.5 F. Hoffmann-La Roche Related Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Corporation Information
11.7.2 Johnson & Johnson Description and Business Overview
11.7.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Johnson & Johnson Biological Drugs Products Offered
11.7.5 Johnson & Johnson Related Developments
11.8 Merck
11.8.1 Merck Corporation Information
11.8.2 Merck Description and Business Overview
11.8.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Merck Biological Drugs Products Offered
11.8.5 Merck Related Developments
11.9 Abbott Laboratories
11.9.1 Abbott Laboratories Corporation Information
11.9.2 Abbott Laboratories Description and Business Overview
11.9.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Abbott Laboratories Biological Drugs Products Offered
11.9.5 Abbott Laboratories Related Developments
11.10 Baxter
11.10.1 Baxter Corporation Information
11.10.2 Baxter Description and Business Overview
11.10.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Baxter Biological Drugs Products Offered
11.10.5 Baxter Related Developments
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Corporation Information
11.1.2 Bristol-Myers Squibb Description and Business Overview
11.1.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bristol-Myers Squibb Biological Drugs Products Offered
11.1.5 Bristol-Myers Squibb Related Developments
11.12 Biogen
11.12.1 Biogen Corporation Information
11.12.2 Biogen Description and Business Overview
11.12.3 Biogen Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Biogen Products Offered
11.12.5 Biogen Related Developments
11.13 GlaxoSmithKline
11.13.1 GlaxoSmithKline Corporation Information
11.13.2 GlaxoSmithKline Description and Business Overview
11.13.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.13.4 GlaxoSmithKline Products Offered
11.13.5 GlaxoSmithKline Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Biological Drugs Market Estimates and Projections by Region
12.1.1 Global Biological Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Biological Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Biological Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Biological Drugs Sales Forecast (2021-2026)
12.2.2 North America: Biological Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Biological Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Biological Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Biological Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Biological Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Biological Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Biological Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Biological Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Biological Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Biological Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Biological Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Biological Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Biological Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Biological Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Biological Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Biological Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Biological Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Biological Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Biological Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Biological Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Biological Drugs Market Segments
Table 2. Ranking of Global Top Biological Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Biological Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Therapeutic Protein
Table 5. Major Manufacturers of Monoclonal Antibody
Table 6. Major Manufacturers of Vaccine
Table 7. Global Biological Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 8. Global Biological Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 9. Global Biological Drugs Sales by Regions 2015-2020 (K MT)
Table 10. Global Biological Drugs Sales Market Share by Regions (2015-2020)
Table 11. Global Biological Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Biological Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 13. Global Biological Drugs Sales Share by Manufacturers (2015-2020)
Table 14. Global Biological Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Biological Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biological Drugs as of 2019)
Table 16. Biological Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Biological Drugs Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Biological Drugs Price (2015-2020) (USD/MT)
Table 19. Biological Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Biological Drugs Product Type
Table 21. Date of International Manufacturers Enter into Biological Drugs Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Biological Drugs Sales by Type (2015-2020) (K MT)
Table 24. Global Biological Drugs Sales Share by Type (2015-2020)
Table 25. Global Biological Drugs Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Biological Drugs Revenue Share by Type (2015-2020)
Table 27. Biological Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 28. Global Biological Drugs Sales by Application (2015-2020) (K MT)
Table 29. Global Biological Drugs Sales Share by Application (2015-2020)
Table 30. North America Biological Drugs Sales by Country (2015-2020) (K MT)
Table 31. North America Biological Drugs Sales Market Share by Country (2015-2020)
Table 32. North America Biological Drugs Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Biological Drugs Revenue Market Share by Country (2015-2020)
Table 34. North America Biological Drugs Sales by Type (2015-2020) (K MT)
Table 35. North America Biological Drugs Sales Market Share by Type (2015-2020)
Table 36. North America Biological Drugs Sales by Application (2015-2020) (K MT)
Table 37. North America Biological Drugs Sales Market Share by Application (2015-2020)
Table 38. Europe Biological Drugs Sales by Country (2015-2020) (K MT)
Table 39. Europe Biological Drugs Sales Market Share by Country (2015-2020)
Table 40. Europe Biological Drugs Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Biological Drugs Revenue Market Share by Country (2015-2020)
Table 42. Europe Biological Drugs Sales by Type (2015-2020) (K MT)
Table 43. Europe Biological Drugs Sales Market Share by Type (2015-2020)
Table 44. Europe Biological Drugs Sales by Application (2015-2020) (K MT)
Table 45. Europe Biological Drugs Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Biological Drugs Sales by Region (2015-2020) (K MT)
Table 47. Asia Pacific Biological Drugs Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Biological Drugs Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Biological Drugs Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Biological Drugs Sales by Type (2015-2020) (K MT)
Table 51. Asia Pacific Biological Drugs Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Biological Drugs Sales by Application (2015-2020) (K MT)
Table 53. Asia Pacific Biological Drugs Sales Market Share by Application (2015-2020)
Table 54. Latin America Biological Drugs Sales by Country (2015-2020) (K MT)
Table 55. Latin America Biological Drugs Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Biological Drugs Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Biological Drugs Revenue Market Share by Country (2015-2020)
Table 58. Latin America Biological Drugs Sales by Type (2015-2020) (K MT)
Table 59. Latin America Biological Drugs Sales Market Share by Type (2015-2020)
Table 60. Latin America Biological Drugs Sales by Application (2015-2020) (K MT)
Table 61. Latin America Biological Drugs Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Biological Drugs Sales by Country (2015-2020) (K MT)
Table 63. Middle East and Africa Biological Drugs Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Biological Drugs Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Biological Drugs Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Biological Drugs Sales by Type (2015-2020) (K MT)
Table 67. Middle East and Africa Biological Drugs Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Biological Drugs Sales by Application (2015-2020) (K MT)
Table 69. Middle East and Africa Biological Drugs Sales Market Share by Application (2015-2020)
Table 70. Bristol-Myers Squibb Corporation Information
Table 71. Bristol-Myers Squibb Description and Major Businesses
Table 72. Bristol-Myers Squibb Biological Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 73. Bristol-Myers Squibb Product
Table 74. Bristol-Myers Squibb Recent Development
Table 75. Eli Lilly Corporation Information
Table 76. Eli Lilly Description and Major Businesses
Table 77. Eli Lilly Biological Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Eli Lilly Product
Table 79. Eli Lilly Recent Development
Table 80. Takeda Corporation Information
Table 81. Takeda Description and Major Businesses
Table 82. Takeda Biological Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Takeda Product
Table 84. Takeda Recent Development
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Major Businesses
Table 87. Pfizer Biological Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Pfizer Product
Table 89. Pfizer Recent Development
Table 90. Amgen Corporation Information
Table 91. Amgen Description and Major Businesses
Table 92. Amgen Biological Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Amgen Product
Table 94. Amgen Recent Development
Table 95. F. Hoffmann-La Roche Corporation Information
Table 96. F. Hoffmann-La Roche Description and Major Businesses
Table 97. F. Hoffmann-La Roche Biological Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. F. Hoffmann-La Roche Product
Table 99. F. Hoffmann-La Roche Recent Development
Table 100. Johnson & Johnson Corporation Information
Table 101. Johnson & Johnson Description and Major Businesses
Table 102. Johnson & Johnson Biological Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Johnson & Johnson Product
Table 104. Johnson & Johnson Recent Development
Table 105. Merck Corporation Information
Table 106. Merck Description and Major Businesses
Table 107. Merck Biological Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Merck Product
Table 109. Merck Recent Development
Table 110. Abbott Laboratories Corporation Information
Table 111. Abbott Laboratories Description and Major Businesses
Table 112. Abbott Laboratories Biological Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Abbott Laboratories Product
Table 114. Abbott Laboratories Recent Development
Table 115. Baxter Corporation Information
Table 116. Baxter Description and Major Businesses
Table 117. Baxter Biological Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. Baxter Product
Table 119. Baxter Recent Development
Table 120. Novartis Corporation Information
Table 121. Novartis Description and Major Businesses
Table 122. Novartis Biological Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Novartis Product
Table 124. Novartis Recent Development
Table 125. Biogen Corporation Information
Table 126. Biogen Description and Major Businesses
Table 127. Biogen Biological Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Biogen Product
Table 129. Biogen Recent Development
Table 130. GlaxoSmithKline Corporation Information
Table 131. GlaxoSmithKline Description and Major Businesses
Table 132. GlaxoSmithKline Biological Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. GlaxoSmithKline Product
Table 134. GlaxoSmithKline Recent Development
Table 135. Global Biological Drugs Sales Forecast by Regions (2021-2026) (K MT)
Table 136. Global Biological Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 137. Global Biological Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 138. Global Biological Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 139. North America: Biological Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 140. North America: Biological Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Europe: Biological Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 142. Europe: Biological Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Asia Pacific: Biological Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 144. Asia Pacific: Biological Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 145. Latin America: Biological Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 146. Latin America: Biological Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Middle East and Africa: Biological Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 148. Middle East and Africa: Biological Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 149. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 150. Key Challenges
Table 151. Market Risks
Table 152. Main Points Interviewed from Key Biological Drugs Players
Table 153. Biological Drugs Customers List
Table 154. Biological Drugs Distributors List
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Biological Drugs Product Picture
Figure 2. Global Biological Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Therapeutic Protein Product Picture
Figure 4. Monoclonal Antibody Product Picture
Figure 5. Vaccine Product Picture
Figure 6. Global Biological Drugs Sales Market Share by Application in 2020 & 2026
Figure 7. Hospitals
Figure 8. Ambulatory Surgical Centers
Figure 9. Others
Figure 10. Biological Drugs Report Years Considered
Figure 11. Global Biological Drugs Market Size 2015-2026 (US$ Million)
Figure 12. Global Biological Drugs Sales 2015-2026 (K MT)
Figure 13. Global Biological Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Biological Drugs Sales Market Share by Region (2015-2020)
Figure 15. Global Biological Drugs Sales Market Share by Region in 2019
Figure 16. Global Biological Drugs Revenue Market Share by Region (2015-2020)
Figure 17. Global Biological Drugs Revenue Market Share by Region in 2019
Figure 18. Global Biological Drugs Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Biological Drugs Revenue in 2019
Figure 20. Biological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Biological Drugs Sales Market Share by Type (2015-2020)
Figure 22. Global Biological Drugs Sales Market Share by Type in 2019
Figure 23. Global Biological Drugs Revenue Market Share by Type (2015-2020)
Figure 24. Global Biological Drugs Revenue Market Share by Type in 2019
Figure 25. Global Biological Drugs Market Share by Price Range (2015-2020)
Figure 26. Global Biological Drugs Sales Market Share by Application (2015-2020)
Figure 27. Global Biological Drugs Sales Market Share by Application in 2019
Figure 28. Global Biological Drugs Revenue Market Share by Application (2015-2020)
Figure 29. Global Biological Drugs Revenue Market Share by Application in 2019
Figure 30. North America Biological Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Biological Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Biological Drugs Sales Market Share by Country in 2019
Figure 33. North America Biological Drugs Revenue Market Share by Country in 2019
Figure 34. U.S. Biological Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Biological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Biological Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Biological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Biological Drugs Market Share by Type in 2019
Figure 39. North America Biological Drugs Market Share by Application in 2019
Figure 40. Europe Biological Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Biological Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Biological Drugs Sales Market Share by Country in 2019
Figure 43. Europe Biological Drugs Revenue Market Share by Country in 2019
Figure 44. Germany Biological Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Biological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Biological Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Biological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Biological Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Biological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Biological Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Biological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Biological Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Biological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Biological Drugs Market Share by Type in 2019
Figure 55. Europe Biological Drugs Market Share by Application in 2019
Figure 56. Asia Pacific Biological Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Biological Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Biological Drugs Sales Market Share by Region in 2019
Figure 59. Asia Pacific Biological Drugs Revenue Market Share by Region in 2019
Figure 60. China Biological Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Biological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Biological Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Biological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Biological Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Biological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Biological Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Biological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Biological Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Biological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Biological Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Biological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Biological Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Biological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Biological Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Biological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Biological Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Biological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Biological Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Biological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Biological Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Biological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Biological Drugs Market Share by Type in 2019
Figure 83. Asia Pacific Biological Drugs Market Share by Application in 2019
Figure 84. Latin America Biological Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Biological Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Biological Drugs Sales Market Share by Country in 2019
Figure 87. Latin America Biological Drugs Revenue Market Share by Country in 2019
Figure 88. Mexico Biological Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico Biological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Biological Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil Biological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Biological Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina Biological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Biological Drugs Market Share by Type in 2019
Figure 95. Latin America Biological Drugs Market Share by Application in 2019
Figure 96. Middle East and Africa Biological Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa Biological Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Biological Drugs Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Biological Drugs Revenue Market Share by Country in 2019
Figure 100. Turkey Biological Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey Biological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Biological Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia Biological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Biological Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 105. U.A.E Biological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Biological Drugs Market Share by Type in 2019
Figure 107. Middle East and Africa Biological Drugs Market Share by Application in 2019
Figure 108. North America Biological Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 109. North America Biological Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Biological Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. Europe Biological Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Biological Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Asia Pacific Biological Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Biological Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Latin America Biological Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Biological Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Middle East and Africa Biological Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
ハウスダストダニアレルギー治療薬の世界市場（～2026年） Market Analysis and Insights: Global House Dust Mite Allergy Drugs Market The global House Dust Mite Allergy Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global House Dust Mite Allergy Drugs Scope and Market Size Hou…- 眼科用治療薬の世界市場（～2026年） Market Analysis and Insights: Global Ophthalmic Therapeutic Drugs Market The global Ophthalmic Therapeutic Drugs market size is projected to reach US$ 16740 million by 2026, from US$ 15860 million in 2020, at a CAGR of 5.2%% during 2021-2026. Global Ophthalmic Therapeutic Drugs Scope and Market Size…
- 生物学的製品製造の世界市場（～2026年） The biological product manufacturing is a complex process which produces products derived from recombinant DNA technology to develop a series of processes to manufacture therapeutic products. A biological product can be a virus, antitoxin, vaccine, blood component or derivative, allergenic product, …
- テネクテプラーゼ薬の世界市場（～2026年） Tenecteplase drug is an enzyme derived through recombinant DNA technology from a human cell line. This enzyme is used to treat thrombus (blood clots) it is also called as clot-busting drug. Tenecteplase is a bioengineered variant of the activase drug. It is estimated that North America dominated the…
- 生物学的安全性試験の世界市場（～2026年） Biological safety testing is carried out to ensure non-contamination of biopharmaceuticals and vaccines and to comply with regulations regarding the same. It is a major step towards the launch of innovative biopharmaceutical products. Biological safety testing is essential to ensure product safety, …